Skip to content
Disclosery

Nextech Invest Ltd.

Follow

13F filer, CIK 1595430, Zurich, Switzerland

Nextech Invest Ltd. reported $2,107,306,424 across 15 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 98.01% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001595430-26-000010

Period
2026-06-30
Reported value
$2.11B
Holdings
15
Top 10 weight
98.01%
New
2
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PBLSnew+4,663,176$128M
RLAYadded+1,250,000$23.4M
GLUEadded+456,916$11.1M
ARVNadded+583,319$8.89M
ENGNnew+2,324,943$4.02M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TNGXexited-7,266,081-$152M
CGEMexited-1,141,145-$16.2M
TYRAreduced-502,276-$16M
ENGNexited-2,324,943-$15.8M
SPRYexited-610,703-$4.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001595430-26-000010, largest first. % of portfolio is the value over $2,107,306,424, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 7,601,087 shares; 2025Q2: 7,601,087 shares; 2025Q3: 7,601,087 shares; 2025Q4: 7,601,087 shares; 2026Q1: 7,601,087 shares; 2026Q2: 7,601,087 shares 7,601,087$1.42B67.55%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,663,176 shares 4,663,176$128M6.06%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 3,846,409 shares; 2025Q2: 3,846,409 shares; 2025Q3: 3,846,409 shares; 2025Q4: 4,701,506 shares; 2026Q1: 5,526,506 shares; 2026Q2: 6,776,506 shares 6,776,506$127M6.02%+1,250,000Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 4,055,861 shares; 2025Q2: 4,055,861 shares; 2025Q3: 4,055,861 shares; 2025Q4: 4,055,861 shares; 2026Q1: 4,055,861 shares; 2026Q2: 3,553,585 shares 3,553,585$114M5.39%-502,276Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,476,998 shares; 2025Q2: 2,915,998 shares; 2025Q3: 2,915,998 shares; 2025Q4: 2,915,998 shares; 2026Q1: 3,540,998 shares; 2026Q2: 3,540,998 shares 3,540,998$99.6M4.73%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 5,285,714 shares; 2025Q2: 7,162,637 shares; 2025Q3: 7,162,637 shares; 2025Q4: 7,162,637 shares; 2026Q1: 7,162,637 shares; 2026Q2: 7,162,637 shares 7,162,637$77.6M3.68%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: 340,909 shares; 2025Q3: 340,909 shares; 2025Q4: 278,896 shares; 2026Q1: 278,896 shares; 2026Q2: 278,896 shares 278,896$32M1.52%0Timeline
ZYMEZYMEWORKS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,113,946 shares; 2025Q2: 1,113,946 shares; 2025Q3: 1,113,946 shares; 2025Q4: 1,113,946 shares; 2026Q1: 1,113,946 shares; 2026Q2: 1,113,946 shares 1,113,946$29.1M1.38%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 279,237 shares; 2026Q1: 304,237 shares; 2026Q2: 761,153 shares 761,153$18.4M0.87%+456,916Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 1,408,394 shares; 2025Q2: 1,408,394 shares; 2025Q3: 1,408,394 shares; 2025Q4: 539,394 shares; 2026Q1: 539,394 shares; 2026Q2: 1,122,713 shares 1,122,713$17.1M0.81%+583,319Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,449,932 shares; 2026Q2: 4,449,932 shares 4,449,932$16.7M0.79%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 952,400 shares; 2025Q2: 952,400 shares; 2025Q3: 952,400 shares; 2025Q4: 952,400 shares; 2026Q1: 952,400 shares; 2026Q2: 952,400 shares 952,400$10.5M0.5%0Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 450,000 shares; 2026Q2: 450,000 shares 450,000$6.72M0.32%0Timeline
CNTXCONTEXT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 7,419,355 shares; 2025Q2: 7,419,355 shares; 2025Q3: 7,419,355 shares; 2025Q4: 7,419,355 shares; 2026Q1: 7,419,355 shares; 2026Q2: 7,419,355 shares 7,419,355$4.11M0.2%0Timeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,324,943 shares 2,324,943$4.02M0.19%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TNGXTANGO THERAPEUTICS INC7,266,081$152Mshares
CGEMCULLINAN THERAPEUTICS INC1,141,145$16.2Mshares
ENGNENGENE HOLDINGS INC2,324,943$15.8Mshares
SPRYARS PHARMACEUTICALS INC610,703$4.9Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001595430-26-000010 base2026-08-14acceptance time not in the bulk data set